Clinigen Group Acquires Clinical Supplies Management from Great Point Partners
September 28, 2018
Clinigen Group PLC has acquired Clinical Supplies Management (CSM), a Malvern, Pennsylvania–based provider of clinical-trial drug packaging, labeling and logistics, from Great Point Partners. The deal includes an initial $150 million cash consideration (cash-free, debt-free) plus up to $90 million in contingent cash tied to EBITDA performance, and is intended to expand Clinigen's global supply and distribution network, particularly in Continental Europe.
- Buyers
- Clinigen Group PLC
- Targets
- Clinical Supplies Management
- Sellers
- Great Point Partners
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Triton (via Triley Bidco) Acquires Clinigen
January 17, 2022
Pharmaceuticals
Triton, through a newly-formed acquisition vehicle Triley Bidco Limited, completed an all-cash recommended offer to acquire Clinigen for 925 pence per share. Triton said it will support Clinigen’s next growth phase by extending geographic reach, pursuing inorganic growth opportunities and strengthening Clinigen’s services and digital platform.
-
Clinigen Acquires SSI Strategy
November 21, 2025
Healthcare Services
Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.
-
GI Partners Acquires Majority Stake in Clinical Ink
August 4, 2020
Cloud & SaaS
GI Partners will acquire a majority interest in Clinical Ink, a global clinical trial technology company headquartered in Horsham, Pennsylvania. The private investment firm will partner with Clinical Ink's management to accelerate product innovation, expand capabilities internationally, and pursue growth; existing investor NovaQuest will remain a minority shareholder. The transaction was expected to close in Q3 2020, subject to customary closing conditions.
-
Proclinic Group (backed by Miura Partners) Acquires Cenger Scandinavia
September 4, 2025
Medical Devices
Proclinic Group, a European dental platform backed by Miura Partners, has acquired Cenger Scandinavia, a leading dental distributor in Denmark with more than 1,300 clients and the number one distributor in the dental laboratory segment. The acquisition marks Proclinic Group's entry into the Nordic market and is intended to expand the Group's European footprint, enhance its service offering for dental professionals, and generate commercial synergies in the region.
-
Great Point Partners Acquires Majority Stake in Lenis Group
December 16, 2025
Healthcare Services
Great Point Partners has acquired a majority stake in Lenis Group, a Ljubljana-based full-service commercialization and distribution partner for niche and specialty prescription medicines across Central and Eastern Europe. The investment will support Lenis's regional expansion, strengthen senior leadership (including appointment of former Biogen CEO Michel Vounatsos as board chairman), and deepen its capabilities in market access, regulatory, medical and distribution services.
-
Caprion-HistoGeneX Acquires Clinical Logistics Inc.
January 7, 2021
Healthcare Services
Caprion-HistoGeneX, a portfolio company backed by Arsenal Capital Partners, has acquired Clinical Logistics Inc. (CLI), a Halifax-based virtual central specimen management CRO. The acquisition expands Caprion-HistoGeneX’s specimen logistics and kitting capabilities to better support global clinical trial operations and specialty specimen handling for pharmaceutical and biotech customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.